Surgical Science Sweden AB (publ)
SSE:SUS.ST
179.1 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Surgical Science Sweden AB (publ) |
Symbool | SUS.ST |
Munteenheid | SEK |
Prijs | 179.1 |
Beurswaarde | 9,138,792,420 |
Dividendpercentage | 0% |
52-weken bereik | 118.8 - 270 |
Industrie | Health Information Services |
Sector | Healthcare |
CEO | Mr. Gisli Hennermark |
Website | https://www.surgicalscience.com |
An error occurred while fetching data.
Over Surgical Science Sweden AB (publ)
Surgical Science Sweden AB (publ) develops and markets virtual reality (VR) simulators for evidence-based laparoscopic and endoscopic training. It offers LapSim training system comprising LapSim ST develops to train surgical technologists and surgical assistants; and LapSim essence, a portable and ready-to-use VR simulator. The company also provides EndoSim system, an
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (SEK)
Cijfers zijn in miljoenen (SEK)